BB Biotech AG (XSWX:BION) Cash Flow from Operations : CHF218.28 Mil (TTM As of Dec. 2023)

BB Biotech AG Cash Flow from Operations Chart

BB Biotech AG Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Cash Flow from Operations		Get a 7-Day Free Trial					215.02	262.45	-94.79	231.13	218.28

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow from Operations	Get a 7-Day Free Trial															-60.30	203.09	8.73	7.39	-0.93

BB Biotech AG Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

BB Biotech AG's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

BB Biotech AG's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:

Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF218.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG  (XSWX:BION) Cash Flow from Operations Explanation

For financial companies reported in direct method, cash flow from operations contains three items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

BB Biotech AG's cash receipts from operating activities for the three months ended in Dec. 2023 was CHF145.68 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

BB Biotech AG's cash payments for the three months ended in Dec. 2023 was CHF-146.61 Mil.

3. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

BB Biotech AG's cash flow from others for the three months ended in Dec. 2023 was CHF-0.00 Mil.

BB Biotech AG Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (XSWX:BION) Business Description